THESEUS PHARMACEUTICALS, INC. General and Administrative Expense
THESEUS PHARMACEUTICALS, INC. reported General and Administrative Expense of $4.88 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2023-09-30 was $4.88M, a 7.93% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2023-06-30 was $4.67M, a 1.44% decline year-over-year.
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2023-03-31 was $4.65M, a 15.46% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2022-12-31 was $5.10M, a 40.12% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for fiscal 2022 was $18.39M, a 104.13% increase from fiscal 2021.
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for fiscal 2021 was $9.01M, a 925.97% increase from fiscal 2020.
- THESEUS PHARMACEUTICALS, INC. general and administrative expense for fiscal 2020 was $878.00K.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $4.88M 10-Q · filed 2023-11-17 | $9.55M derived: sum of 2 quarters · filed 2023-11-17 | $14.21M 10-Q · filed 2023-11-17 | $19.30M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $4.67M 10-Q · filed 2023-08-10 | $9.32M 10-Q · filed 2023-08-10 | $14.42M derived: sum of 3 quarters · filed 2023-08-10 | $18.94M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $4.65M 10-Q · filed 2023-05-11 | $9.75M derived: sum of 2 quarters · filed 2023-05-11 | $14.28M derived: sum of 3 quarters · filed 2023-11-17 | $19.01M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $9.62M derived: sum of 2 quarters · filed 2023-11-17 | $14.36M derived: sum of 3 quarters · filed 2023-11-17 | $18.39M 10-K · filed 2023-03-09 |
| 2022-09-30 | $4.53M 10-Q · filed 2023-11-17 | $9.26M derived: sum of 2 quarters · filed 2023-11-17 | $13.29M 10-Q · filed 2023-11-17 | $16.93M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-06-30 | $4.74M 10-Q · filed 2023-08-10 | $8.77M 10-Q · filed 2023-08-10 | $12.40M derived: sum of 3 quarters · filed 2023-08-10 | $14.78M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $4.03M 10-Q · filed 2023-05-11 | $7.67M derived: sum of 2 quarters · filed 2023-05-11 | $10.05M derived: sum of 3 quarters · filed 2023-05-11 | $12.38M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $6.01M derived: sum of 2 quarters · filed 2023-03-09 | $8.34M derived: sum of 3 quarters · filed 2023-03-09 | $9.01M 10-K · filed 2023-03-09 |
| 2021-09-30 | $2.38M 10-Q · filed 2022-11-03 | $4.71M derived: sum of 2 quarters · filed 2022-11-03 | $5.37M 10-Q · filed 2022-11-03 | $5.77M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $2.33M 10-Q · filed 2022-08-11 | $2.99M 10-Q · filed 2022-08-11 | $3.39M derived: sum of 3 quarters · filed 2022-08-11 | $3.55M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $664.00K 10-Q · filed 2022-05-12 | $1.06M derived: sum of 2 quarters · filed 2022-05-12 | $1.22M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $554.00K derived: sum of 2 quarters · filed 2022-03-10 | $878.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $154.00K 10-Q · filed 2021-11-15 | $478.00K 10-Q · filed 2021-11-15 |